SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-001912
Filing Date
2015-05-14
Accepted
2015-05-13 18:53:59
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 552351
2 ex31-1.htm EX-31.1 14327
3 ex31-2.htm EX-31.2 16062
4 ex32-1.htm EX-32.1 5292
5 ex32-2.htm EX-32.2 5447
  Complete submission text file 0001493152-15-001912.txt   6931303

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE corx-20150331.xml EX-101.INS 800355
7 XBRL SCHEMA FILE corx-20150331.xsd EX-101.SCH 69736
8 XBRL CALCULATION FILE corx-20150331_cal.xml EX-101.CAL 47090
9 XBRL DEFINITION FILE corx-20150331_def.xml EX-101.DEF 303004
10 XBRL LABEL FILE corx-20150331_lab.xml EX-101.LAB 488832
11 XBRL PRESENTATION FILE corx-20150331_pre.xml EX-101.PRE 364496
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 15859796
SIC: 2834 Pharmaceutical Preparations